Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sickle cell disease
3
×
startups
3
×
abbvie
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adverum biotechnologies
akouos
albert bourla
allergan
alnylam pharmaceuticals
What
acquisitions
bio
ceo
medicines
roundup
aims
albert
announced
approach
based
biggest
biotech
bourla
called
collabs
company
covid
crispr
daniel
deal
debuts
developing
drug
drugs
epigenetic
epigenetics
field
flagship’s
future
gilead
gilead’s
help
imports
introduce
ipo
maker
maps
measured
month
morning
Language
unset
unknown
Current search:
startups
×
" sickle cell disease "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More